Open Access

Solitary preperitoneal neurofibroma: a case report

  • Noureddine Njoumi1Email author,
  • Mohamed Elabsi1,
  • Gilles Attolou1,
  • Hafsa Elouazzani2,
  • Faricha Hassan Elalami1 and
  • Mohamed Rachid Chkoff1
BMC Research Notes20158:115

https://doi.org/10.1186/s13104-015-1098-8

Received: 30 July 2014

Accepted: 26 March 2015

Published: 1 April 2015

Abstract

Background

Neurofibroma is a rare benign tumor. The isolated presence of such lesions in the preperitoneal space with no evidence of systemic disease has never been reported in the literature.

Case presentation

A 29-year-old white man presented with a 12 months history of progressive abdominal distension. Clinical examination revealed a bulky hypogastric mass. Abdominal computed tomography and pelvic magnetic resonance imaging showed a large, well defined preperitoneal tumor measuring 18 x 17cm extending in the pelvis. A computed tomography guided biopsy was performed which revealed a neurofibroma. Exploratory laparotomy showed a well encapsulated elastic soft tumor in the preperitoneal space which measured 17 x 18cm and weighted 2 Kg. The tumor was completely excised. No recurrence occurred after one year of follow-up.

Conclusion

Solitary preperitoneal neurofibroma is an extremely rare benign tumor. Its clinical and radiological signs are nonspecific. Preoperative histology can be useful to guide the surgical approach which is the only curative treatment.

Keywords

Solitary neurofibroma Benign tumor Preperitoneal space

Background

Neurofibroma is an uncommon benign tumor arising from the peripheral nerve sheaths. The isolated presence of neurofibromatous lesions in the preperitoneal space (between the parietal peritoneum and transversalis fascia), without any other sign of von Recklinghausen’s disease has rarely been reported [1]. Authors report an unusual case with a review of literature.

Case presentation

A 29-year-old white man, with no history of neurofibromatosis or other systemic disease, was complaining of insidious and progressive abdominal distension which appeared 12 months prior to admission. He had hypogastric abdominal pain and pollakiuries in the preceding five months. There were no vomiting or transit disorders, and no neurological symptoms.

On clinical examination, the patient was in good general condition with a normal temperature, a body mass index of 24 and no café au-lait spots or dermal neurofibromas on his body. The palpation of the abdomen revealed a well-defined, fixed and painless hypogastric mass, 20 cm in diameter. Digital rectal examination was normal.

All the standard hematological and serum biochemical data were normal.

An abdomino-pelvic computed tomography (CT) scan (Figure 1) revealed a massive, inhomogeneous, hypodense, preperitoneal tumor, measuring 17 × 18cm extending in the pelvis, crushing both ureters and compressing the bladder. This mass was moderately enhanced with contrast. There were no signs of pelvic invasion or intraperitoneal effusion. Both kidneys were increased in size with dilation of renal cavities but the renal cortex was preserved.
Figure 1

Abdomino-pelvic computed tomography showed a massive, inhomogeneous, hypodense abdominal tumor.

Pelvic magnetic resonance imaging (Figure 2) revealed a large, well encapsulated preperitoneal tumor, slightly compressing the bladder and the pelvic ureters without invasion of the adjacent structures and without pelvic bone localization.
Figure 2

Pelvic magnetic resonance imaging showing a large, well encapsulated preperitoneal tumor.

A CT-guided biopsy was performed revealing a conjunctive tissue separated by a fuso-cellular proliferation compound of Schwann cells with regular nuclei immersed in a richly vascularized and myxoid fibrillar background. There was no evidence of malignancy within the tissue obtained. Immunohistochemically, the tumor cells were strongly positive for the S100 and the neurofilament proteins evoking a neurofibroma.

Surgical resection was decided by the multidisciplinary meeting for cancer care. Exploratory laparotomy revealed a well encapsulated elastic soft tumor in the preperitoneal space. Upon incision of the linea alba, there was a protrusion of the mass. It was easily cleaved before the opening of the anterior parietal peritoneum. At the end of excision, there was a peritoneal break due to size of the mass (Figure 3).
Figure 3

Intraoperative view showing the well encapsulated elastic soft tumor in the preperitoneal space.

The tumor measured 17 × 18 cm and weighted 2 Kg (Figure 4). It was completely excised without macroscopic capsule breaking. No lymph nodes or other palpable intra-abdominal masses were discovered.
Figure 4

Macroscopic appearance of the preperitoneal neurofibroma; size = 17x18cm, weight = 2 kg.

The histological and immuno-histochemical analysis of the surgical specimen confirmed the preoperative diagnosis (Figure 5). Thus, the tumor was diagnosed as a solitary neurofibroma. The post-operative course was uneventful. No adjuvant treatment was indicated. The patient remains well without any sign of tumor recurrence on a CT scan performed 12 months after surgery.
Figure 5

Benign tumor cells immersed in a myxoid collagen background (A) with elongated and wavy nuclei (B).

Comments

Neurofibroma is a tumor of neural origin derived from the cells that constitute the nerve sheath. It’s an uncommon benign tumor found as a solitary tumor or as a partial manifestation of neurofibromatosis type I (NF1, also called von Recklinghausen’s disease) [2]. The cause of solitary neurofibroma is still unknown [3], it is defined by Marocchio et al. [4] as a hyperplastic hamartomatous malformation rather than neoplastic. NF1 is an autosomal dominant genetic syndrome caused by mutations in genes coding for neurofibromin [5], it is characterized by cutaneous manifestations as cafe-au-lait spots with a large number of nervous system tumors [6]. The hereditary factors and systemic symptoms present in the disseminated neurofibromas are absent in the solitary type [7].

This kind of neoplasms is known to mainly affect the cutaneous nerves of the trunk, neck, and head [8,9]. Rare cases in the deep organs or in the peritoneal cavity were also reported [10]. Concerning the retroperitoneal location, exceptional cases of benign nerve sheaths tumors were reported in large series of primitive retroperitoneal tumors [11,12]. To our knowledge, the presence of solitary neurofibroma in the preperitoneal space has never been reported in the literature.

Neurofibroma appears to affect adolescents and young adults without a gender preference. It grows along the peripheral nerves as a non-encapsulated focal mass with well-defined margins [8,9].

The clinical manifestations of solitary neurofibromas are not specific and change according to their locations, their effect on gastrointestinal motility and their possible impingement on contiguous structures, resulting in palpable masses, abdominal pain, and transit disorders due to extra-luminal pressure [13-15]. The deep seated neurofibroma on peripheral nerves and spinal roots frequently leads to neurological disability [16].

Intra pelvic tumors are often diagnosed at a late stage which is source of surgical resection difficulties [17].

Preoperative imaging is usually insufficient to establish the diagnosis with certainty, only the histology can do. In fact, the preoperative histological evidence can influence the treatment modifying the surgical approach, conservative versus aggressive [10].

Surgical removal is the only treatment option. Unlike our case, neurofibromas are difficult to manage surgically as they are extensively infiltrative and highly vascular [15,18].

Some authors posit that surgical resection is indicated only when the tumor causes pain, neurological deficiencies or when there is a strong suspicion of malignancy [19].

Solitary neurofibromas have a good prognosis, with rare instances of haemorrhage, malignant changes and local recurrences after excision [18,20].

Conclusion

The solitary preperitoneal neurofibroma is an extremely rare benign tumor arising from nerve sheaths. Its clinical and radiological signs are not specific. Preoperative histological diagnosis can be useful to help choosing the surgical approach, which is the gold-standard treatment option. Unlike other sites, tumor excision in the preperitoneal location remains without difficulties.

Consent

Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Abbreviations

CT: 

Computed tomography

NF1: 

Neurofibromatosis type I

Declarations

Authors’ Affiliations

(1)
Department of Visceral Surgical Emergency, Ibn Sina Hospital
(2)
Department of Anatomical Pathology, Ibn Sina Hospital

References

  1. Al-Harake A, Chour M, Al Beteddini OS. Solitary intestinal neurofibroma with no associated systemic syndromes causing intussusception: Case report and literature review. Int J Surg Case Rep. 2013;4(7):629–32.View ArticlePubMed CentralPubMedGoogle Scholar
  2. Ishikawa J, Kamidono S, Maeda S, Sugiyama T, Hara I, Takechi Y, et al. Solitary retroperitonea neurofibroma: a case report. Hinyokika Kiyo. 1989;35(7):1157–60.PubMedGoogle Scholar
  3. De Raedt T, Maertens O, Chmara M, Brems H, Heyns I, Sciot R, et al. Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patient. Genes Chromosomes Cancer. 2006;45(10):893–904.View ArticlePubMedGoogle Scholar
  4. Marocchio LS, Oliveira DT, Pereira MC, Soares CT, Fleury RN. Sporadic and multiple neurofibromas in the head and neck region: a retrospective study of 33 years. Clin Oral Investig. 2007;11(2):165–9.View ArticlePubMedGoogle Scholar
  5. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res. 2002;62(5):1573–7.PubMedGoogle Scholar
  6. Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J. Harrison’s principles of internal medicine. 18th ed. New York: McGraw-Hill; 2012.Google Scholar
  7. Depprich R, Singh DD, Reinecke P, Kübler NR, Handschel J. Solitary submucous neurofibroma of the mandible: review of the literature and report of a rare case. Head Face Med. 2009;5:24.View ArticlePubMed CentralPubMedGoogle Scholar
  8. Lee YB, Lee JI, Park HJ, Cho BK. Solitary neurofibromas: does an uncommon site exist? Ann Dermatol. 2012;24(1):101–2.View ArticlePubMed CentralPubMedGoogle Scholar
  9. Ameur A, Lezrek M, Jira H, el Alami M, Beddouch A, Abbar M. Neurofibrome rétropéritonéal solitaire géant. Prog Urol. 2002;12(3):465–8.PubMedGoogle Scholar
  10. Van Sandick JW, van Coevorden F. Plexiform neurofibroma with intraspinal extension. J Am Coll Surg. 2002;195(4):572.View ArticlePubMedGoogle Scholar
  11. Pinson CW, ReMine SG, Fletcher WS, Braasch JW. Long term results with primary retropritoneal tumors. Arch Surg. 1989;124(10):1168–73.View ArticlePubMedGoogle Scholar
  12. Scanlan DB. Primary retroperitoneal tumors. J Urol. 1959;81(6):740–5.PubMedGoogle Scholar
  13. Panteris V, Vassilakaki T, Vaitsis N, Elemenoglou I, Mylonakou I, Karamanolis DG. Solitary colonic neurofibroma in a patient with transient segmental colitis: case report. World J Gastroenterol. 2005;11(35):5573–6.PubMed CentralPubMedGoogle Scholar
  14. Carter JE, Laurini JA. Isolated intestinal neurofibromatous proliferations in the absence of associated systemic syndromes. World J Gastroenterol. 2008;14(42):6569–71.View ArticlePubMed CentralPubMedGoogle Scholar
  15. Honeypalsinh HM, Girish S. An Unusual Presentation of Anterior Abdominal Wall Neurofibroma. Int J Biol Med Res. 2013;4(4):3731–2.Google Scholar
  16. Blakely P, Louis DN, Short MP, MacCollin M. A clinical study of patients with multiple isolated neurofibromas. J Med Genet. 2001;38(7):485–8.View ArticleGoogle Scholar
  17. Feldenzer JA, McGauley JL, McGillicuddy JE. Sacral and presacral tumors: problems in diagnosis and management. Neurosurgery. 1989;25(6):884–91.View ArticlePubMedGoogle Scholar
  18. Jones RG, Kiatisevi P, Morris DC, Munk PL, Clarkson PW, Masri BA. Intravascular embolisation and surgical resection ofa giant neurofibroma with intratumoural haemorrhage. Br J Radiol. 2010;83(995):e225–9.View ArticlePubMed CentralPubMedGoogle Scholar
  19. Kubiena H, Entner T, Schmidt M, Frey M. Peripheral neural sheath tumors (PNST) what a radiologist should know. Eur J Radiol. 2013;82(1):51–5.View ArticlePubMedGoogle Scholar
  20. Corbellini C, Vingiani A, Maffini F, Chiappa A, Bertani E, Andreoni B. Retroperitoneal pararenal isolated neurofibroma: report of a case and review of literature. Ecancermedicalscience. 2012;6:253.PubMed CentralPubMedGoogle Scholar

Copyright

© Njoumi et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement